p4hd

A look at life science innovation brought on by physician-biopharm tech hybrids

In this series, Dialogues+ is taking a look at innovation brought about through collaborations between physicians and biopharmaceutical/medical technology companies. Today, we look to potential future innovations and recent developments from the National Institutes of Health. Accelerating Medicines Partnership In February 2014, the National Institutes of Health (NIH) announced a new public-private partnership, the Accelerating […]

By Jon Tripp

BioPharma

P4HD Partners respond to USA Today letter written by John J. Castellani & Jim Greenwood

On February 24, USA Today ran a letter to the editor written by PhRMA President John J. Castellani and Biotechnology Industry Organization President Jim Greenwood responding to an editorial that not only mischaracterized the relationships between physicians and biopharmaceutical and medical technology professionals, but also admonished them. An additional rebuttal by Dr. Thomas Stossel, Professor […]

By Jon Tripp

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.